Kirkwood, J., R. Dummer, A. Hauschild, M. Santinami, V. Atkinson, V. Sileni, J. Larkin, M. Nyakas, A. Haydon, C. Dutriaux, J. Schachter, C. Robert, L. Mortier, H. Banerjee, T. Haas, M. Tan, M. Lau, D. Schadendorf, G. Long, and M. Mandala. “Restricted Mean Survival Time and Cure-Rate Modeling in Estimating Relapse-Free Survival Benefit With Adjuvant Dabrafenib + Trametinib Treatment in Melanoma”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 1, Jan. 2021, p. s2, doi:10.25251/skin.5.supp.2.